[[{“value”:”
**Considerations for the Perfect Biomanufacturing Site**
Biomanufacturing involves the use of biologics—such as cell lines, enzymes, or microorganisms—to produce a wide range of commercial products, including pharmaceuticals and food ingredients. As global demand for these biologically derived products continues to rise, so does the need for specialized manufacturing facilities. However, establishing a biomanufacturing plant is far more complex than setting up a traditional factory. Site selection is driven by a unique set of considerations, as highlighted in a recent report by CBRE.
Here are three critical factors that companies must prioritize when choosing a location for biomanufacturing operations:
**1. Labor and Infrastructure**
Biomanufacturing demands a highly skilled workforce and extensive infrastructure. According to CBRE, the energy consumption of these facilities can be up to 14 times greater than that of standard manufacturing operations. Additionally, the resulting wastewater requires advanced treatment solutions to meet environmental standards.
Due to the financial investment involved, companies should adopt a data-driven, holistic approach to site selection. Key considerations include labor cost and availability, access to power and water, and the potential for state and local incentives. A well-informed decision can significantly impact long-term operational efficiency and cost-effectiveness.
**2. Supply Diversification**
The COVID-19 pandemic exposed critical vulnerabilities in global supply chains, prompting biomanufacturing companies to reevaluate their strategies. In response, many are shifting toward localized production of essential materials to mitigate risk and avoid tariffs.
This trend necessitates the expansion of U.S.-based operations, often requiring multiple sites and parallel capital projects to ensure stable and resilient supply chains.
**3. Abundant Capital**
Biomanufacturing facilities require not only a steady flow of resources and skilled labor but also significant financial investment. Real estate decisions often involve purchasing the site outright to protect production capabilities and specialized equipment.
This approach can lead to substantial capital expenditures across multiple initiatives. Financial flexibility—through avenues like new development funding, sale-leaseback arrangements, or other liquidity-enhancing strategies—is essential to support these ventures.
As biomanufacturing continues to expand, selecting the right site becomes increasingly consequential. By evaluating labor markets, infrastructure capacity, supply chain strategy, and financial models, companies can position themselves for long-term success in this rapidly evolving industry.
“}]]
